Abstract | OBJECTIVE: To determine the quantitive and functional changes of circulating endothelial progenitor cells (EPCs) in dogs with dehydromonocrotaline-induced pulmonary artery hypertension (PAH). METHODS:
Dehydromonocrotaline was injected into the canine right ventricle to induce pulmonary hypertension. Circulating EPCs were enumerated as AC+(113), KDR+ cells by fluorescence-activated cell sorter using counting beads, and the number and activity of EPCs after in vitro expansion were determined by acLDL uptake/ lectin staining assay and in vitro tubule forming assay. RESULTS: Nine of the 10 beagles survived after dehydromonocrotaline injection. Six weeks later, mean pulmonary artery pressure increased from (11.3 +/- 2.0) mm Hg (1 mm Hg = 0.133 kPa) to (20.2 +/- 1.6) mm Hg (t =10.307, P < 0.01), and the AC+(133) and KDR+ cells decreased from (632.8 +/- 42.8) cells/ml to (206.1 +/- 26.8) cells/ml (t = 25.361, P < 0.01). UEA- I and DiLDL positive cells deceased from (41 +/- 6) EPCs/ x 200 field to (22 +/- 6) EPCs/ x 200 field (t = 6.510, P < 0.01). In addition, in vasculogenesis assay, PAH EPCs formed less quantitative (11.2 +/- 2.8 vs 21.1 +/- 2.8 tubules/ x 200 field, respectively, t = 7. 583, P <0. 01) and less qualitive tubules than baseline EPCs. CONCLUSION:
|
Authors | Chun-Lai Zeng, Liang Xia, Cai-Yan Ma, Shan-Kuan Liu, Xiao-Sheng Hu, Xing-Xiang Wang, Jun-Zhu Chen |
Journal | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
(Zhonghua Jie He He Hu Xi Za Zhi)
Vol. 31
Issue 5
Pg. 330-4
(May 2008)
ISSN: 1001-0939 [Print] China |
PMID | 18953955
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- monocrotaline pyrrole
- Monocrotaline
|
Topics |
- Animals
- Cell Count
- Cells, Cultured
- Disease Models, Animal
- Dogs
- Endothelial Cells
(drug effects)
- Hypertension, Pulmonary
(chemically induced, pathology, physiopathology)
- Male
- Monocrotaline
(adverse effects, analogs & derivatives)
- Pulmonary Circulation
- Stem Cells
(drug effects)
|